Key Imperial academics are among those to be recognized on the 2022 New Year’s Honor Roll.
This story is being updated
Members of the Imperial Community to receive honors include Professor Robin Grimes, BCH Steele Chair in Energetic Materialss in the materials department, who was made a Bachelor Knight for services to UK Resilience and international scientific relations.
Professor Wendy Barclay, Head of the Department of Infectious Diseases at Imperial College London and Chair of Influenza Virology, received a CBE for her contributions to the study of viruses and her research during the COVID-19 pandemic. Professor Peter Openshaw, Professor of Experimental Medicine at Imperial’s National Heart and Lung Institute, also receives a CBE for medical and immunological services.
Dr Justin Roe, Honorary Clinical Lecturer in the Department of Surgery and Cancer at Imperial, receives an MBE for his speech therapy services, while Lesley Rawlinson, Llaboratory director at Imperial Department of Infectious Diseases, receives British Empire Medal for COVID-19 response services.
Chivalry: Professor Robin Grimes
of Professor Robin Grimes research is focused on the application and development of computer simulation techniques to predict the structural and dynamic properties of ceramics and metals for energy applications – in particular nuclear.
Since 1984 he is the author on 300 peer-reviewed publications. He has served as Chief Science Adviser (Nuclear) for the Department of Defense and Chief Science Adviser for the Department of Foreign and Commonwealth Affairs.
Professor Grimes continues to play an active role in strengthening engagement with scientists around the world, including Japan, Argentina and India. He was elected Minister of Foreign Affairs of the Royal Society in 2021.
Professor Robin Grimes said: “I am grateful to my excellent colleagues and the environment at Imperial Oil which allowed me to carry out this important work within Government. I am honored receive this recognition.
Professor Wendy Barclay CBE
Beginning his career in what was then the Common Cold Unit at Salisbury and the University of Reading, Professor Barclay’s research has focused on respiratory viruses and factors affecting their capacity for transmission and disease.
In nearly 15 years at Imperial, his work has provided key insights into the molecular aspects of the host range, transmissibility and pathogenicity of viruses such as influenza, rhinovirus and SARS-CoV-2. She has contributed to the understanding of how these viruses cause pandemics and how best to use vaccines and antiviral treatments to fight them.
It was the proudest moment of my life to tell my husband and two sons that I will be honored in this way. ” Professor Wendy Barclay Department of Infectious Diseases
Throughout the COVID-19 pandemic, his collaborations with Public Health England (now the UK Health Security Agency) and his roles on several government advisory committees provided critical evidence on emerging threats from SARS-CoV-2 and its variants. This work covers basic virology and immunology as well as the analysis of environmental samples for traces of the virus.
Playing a key role in Imperial’s COVID-19 response, Professor Barclay’s team continues to work on molecular analysises for projects including: the REACT study on virus and antibody surveillance in the community; ATACCC studies domestic transmission; ISARIC-4C, which collects and analyzes samples from hospitalized COVID-19 patients; and the study on the human challenge COVID-19.
Her too is a member of the National Baseline Study on the Transmission of SARS CoV2, PROTECT and she leads the UK Virology from genotype to phenotype (G2P) Consortium, created to study the impact of mutations in the SARS-CoV-2 coronavirus and help UKHSA assess the risks of new variants in real time as they arise..
Commenting on his honor, Professor Barclay said: “I am truly grateful to have been nominated for this award. The past two years have been extremely busy and I could not have accomplished anything without the unwavering support of the people I work with, my lab and my new and old collaborators. But especially my family – it was the proudest moment of my life to tell my husband Dan and my two sons, Harry and Fergus, that I will be honored in this way. ”
Professor Peter Openshaw CBE
Professor Peter Openshaw is a pulmonologist and mucosal immunologist, studying how the immune system both protects against viral infections but also causes disease. He has been a central figure in Imperial’s response to COVID-19, providing crucial information on the progression and spread of the disease.
Professor Openshaw said: “I am very happy with this award which recognizes not only my work but also the fantastic teams that I have had the privilege of working with for many years. It is wonderful to have recruited a series of brilliant young researchers who are now academic leaders themselves, or who have held good positions in other fields. “
He co-directs ISARIC4C a UK-wide consortium of doctors and scientists established in 2020 to study the COVID-19 pandemic, modeled on the MOSAIC consortium it created in 2009 to study pandemic influenza. ISARIC4C provides a foundation for the UK’s outbreak response, sharing samples and data to help researchers around the world respond quickly, openly and in the public interest to urgent questions about COVID-19.
Professor Openshaw has been working on RSV and influenza since the mid-1980s, leading studies of experimental human infection of volunteers since 2008. He is director of the MRC-funded HIC-Vac consortium created to promote the use of human experimental infection to accelerate vaccination. development of pathogens with high global impact. He is a co-researcher for a historic human challenge study for COVID-19 at Imperial which helps understand the disease course in people with mild infections and investigate the detailed natural history of SARS-CoV-2 infection.
Professor Openshaw is Vice-Chair of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG), which advises the government on the threat posed by new and emerging respiratory viruses. He was President of the British Society for Immunology from 2013 to 2018.